Comment on

• Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

  White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators. White WB, et al. N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992602 Clinical Trial.
• Saxagliptin, alogliptin, and cardiovascular outcomes.

  Standl E. Standl E. N Engl J Med. 2014 Jan 30;370(5):483. doi: 10.1056/NEJMc1313880. N Engl J Med. 2014. PMID: 24476445 No abstract available.